Mechanism of Action Comparison IGF-1 LR3 Reduced IGFBP-1, -2, -3 binding affinity Extended circulating half-life (~20-30 hours) Sustained IGF-1 receptor activation Full receptor binding affinity maintained IGF-1 DES Reduced IGFBP binding via truncation Short half-life (~20-30 minutes) Rapid, acute receptor activation Enhanced receptor binding potency reported Research Applications Comparison The choice between IGF-1 LR3 and IGF-1 DES depends on the specific temporal requirements of your research
During your initial consultation, PlexusDx clinicians evaluate your medical history, current medications, lifestyle, and weight loss goals to determine whether semaglutide or an alternative GLP-1 therapy (such as tirzepatide or a dual-compound formulation) is most appropriate for your clinical profile
When injected properly into the fatty layer of the abdomen or thigh, the process is practically painless, making it exceptionally easy to integrate into a standard weekly routine
That dual mechanism, reduced input plus increased output, explains the dramatic differences in clinical trial results
%25201.png)
